Table 5.
Predictors variables | Bivariable analyses
|
Multivariable modela,b
|
||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Age | 0.99 | 0.98–1.01 | 0.45 | 0.99 | 0.97–1.00 | 0.14 |
Female sex | 1.59 | 0.99–2.57 | 0.05 | 1.70 | 0.99–2.92 | 0.05 |
Drug/alcohol abuse | 0.58 | 0.07–5.00 | 0.62 | |||
Palliative care goal | 0.75 | 0.47–1.20 | 0.23 | |||
Head/neck metastases | 0.25 | 0.06–1.08 | 0.06 | 0.26 | 0.05–1.32 | 0.10 |
CNS metastases | 0.47 | 0.13–1.62 | 0.23 | |||
Radiotherapy in last 30 days | 0.53 | 0.32–0.85 | 0.009 | 0.45 | 0.26–0.79 | 0.006 |
DN4 positive | 0.74 | 0.46–1.19 | 0.21 | 0.54 | 0.30–0.97 | 0.04 |
Incident pain | 0.65 | 0.41–1.05 | 0.07 | |||
No opioids | 8.89 | 4.38–18.04 | <0.001 | |||
Adjuvants≥1 | 0.64 | 0.40–1.02 | 0.06 | 0.57 | 0.32–0.99 | 0.05 |
Pain duration>3 months | 1.27 | 0.79–2.02 | 0.32 | |||
ET_need help>4 | 0.60 | 0.37–0.97 | 0.04 | 0.55 | 0.32–0.96 | 0.03 |
BPI_interference with walking | 1.08 | 0.98–1.18 | 0.12 | 1.09 | 0.98–1.21 | 0.13 |
BPI_interference with general activity | 1.14 | 1.03–1.25 | 0.009 | 1.14 | 1.02–1.27 | 0.02 |
BPI_pain relief | 0.96 | 0.95–0.97 | <0.001 | 0.97 | 0.96–0.98 | <0.001 |
Intercept | 1.28 | 0.20–8.09 | 0.79 |
Notes:
Model’s goodness of fit: Hosmer–Lemeshow chi-square=6.33 (p=0.61).
Model’s discrimination: area under ROC=0.782.
Abbreviations: BPI, Brief Pain Inventory; CI, confidence interval; CNS, central nervous system; DN4, “Douleur Neuropathique 4” (neuropathic pain diagnostic questionnaire); ET, Emotion Thermometer; OR, odds ratio; PMI, pain management index; ROC, receiver operating characteristic curve.